Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kojiro Tashiro

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Japanese Journal of Clinical Oncology|April 8, 2025
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective studyFumihiko Urabe, Yuki Taneda, Naoki Uchida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 27, 2023
The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter studyJuria Nakano, Fumihiko Urabe, Yuria Kiuchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 2024
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohortMasashi Kato, Masaki Shiota, Takahiro Kimura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 13, 2023
Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort studyYushi Suhara, Fumihiko Urabe, Kentaro Yoshihara, et al.
Clinical Genitourinary Cancer|May 10, 2025
Optimal Cystoscopic Surveillance Schedule Following Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaYuhei Koike, Fumihiko Urabe, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology|January 25, 2026
Tumor cell invasion of blood vessels predicts poor survival in upper tract urothelial carcinoma following radical nephroureterectomyMiyaka Umemori, Shun Sato, Fumihiko Urabe, et al.
Japanese Journal of Clinical Oncology|November 19, 2025
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort studyKosuke Iwatani, Fumihiko Urabe, Keiichiro Mori, et al.
Urologic Oncology|March 1, 2025
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter studyFumihiko Urabe, Kojiro Tashiro, Katsuki Muramoto, et al.
BJU International|July 19, 2025
Clinical features of medication-related osteonecrosis of the jaw in prostate cancer managementYuma Goto, Fumihiko Urabe, Yue Ogihara, et al.
Japanese Journal of Clinical Oncology|January 17, 2025
Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative studyYuki Taneda, Fumihiko Urabe, Naoki Uchida, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Japanese Journal of Clinical Oncology|April 8, 2025
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective studyFumihiko Urabe, Yuki Taneda, Naoki Uchida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 27, 2023
The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter studyJuria Nakano, Fumihiko Urabe, Yuria Kiuchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 2024
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohortMasashi Kato, Masaki Shiota, Takahiro Kimura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 13, 2023
Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort studyYushi Suhara, Fumihiko Urabe, Kentaro Yoshihara, et al.
Clinical Genitourinary Cancer|May 10, 2025
Optimal Cystoscopic Surveillance Schedule Following Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaYuhei Koike, Fumihiko Urabe, Katsuki Muramoto, et al.
Japanese Journal of Clinical Oncology|January 25, 2026
Tumor cell invasion of blood vessels predicts poor survival in upper tract urothelial carcinoma following radical nephroureterectomyMiyaka Umemori, Shun Sato, Fumihiko Urabe, et al.
Japanese Journal of Clinical Oncology|November 19, 2025
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort studyKosuke Iwatani, Fumihiko Urabe, Keiichiro Mori, et al.
Urologic Oncology|March 1, 2025
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter studyFumihiko Urabe, Kojiro Tashiro, Katsuki Muramoto, et al.
BJU International|July 19, 2025
Clinical features of medication-related osteonecrosis of the jaw in prostate cancer managementYuma Goto, Fumihiko Urabe, Yue Ogihara, et al.
Japanese Journal of Clinical Oncology|January 17, 2025
Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative studyYuki Taneda, Fumihiko Urabe, Naoki Uchida, et al.
Pageof 10